BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10233465)

  • 41. A phase IIA dose-finding study of PVP-hypericin fluorescence cystoscopy for detection of nonmuscle-invasive bladder cancer.
    Straub M; Russ D; Horn T; Gschwend JE; Abrahamsberg C
    J Endourol; 2015 Feb; 29(2):216-22. PubMed ID: 25222735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies.
    Zaak D; Kriegmair M; Stepp H; Stepp H; Baumgartner R; Oberneder R; Schneede P; Corvin S; Frimberger D; Knüchel R; Hofstetter A
    Urology; 2001 Apr; 57(4):690-4. PubMed ID: 11306382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel endoscopic diagnosis for bladder cancer.
    Lerner SP; Goh A
    Cancer; 2015 Jan; 121(2):169-78. PubMed ID: 25132313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluorescence detection of flat transitional cell carcinoma after intravesical instillation of aminolevulinic acid.
    D'Hallewin MA; Vanherzeele H; Baert L
    Am J Clin Oncol; 1998 Jun; 21(3):223-5. PubMed ID: 9626785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autofluorescence imaging to optimize 5-ALA-induced fluorescence endoscopy of bladder carcinoma.
    Frimberger D; Zaak D; Stepp H; Knüchel R; Baumgartner R; Schneede P; Schmeller N; Hofstetter A
    Urology; 2001 Sep; 58(3):372-5. PubMed ID: 11549483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells.
    Steinbach P; Kriegmair M; Baumgartner R; Hofstädter F; Knüchel R
    Urology; 1994 Nov; 44(5):676-81. PubMed ID: 7974943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer].
    Daniltchenko D; Riedl C; Koenig F; Daha LK; Sachs M; Schnorr D
    Aktuelle Urol; 2004 Nov; 35(6):497-501. PubMed ID: 15526230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study.
    Daneshmand S; Patel S; Lotan Y; Pohar K; Trabulsi E; Woods M; Downs T; Huang W; Jones J; O'Donnell M; Bivalacqua T; DeCastro J; Steinberg G; Kamat A; Resnick M; Konety B; Schoenberg M; Jones JS;
    J Urol; 2018 May; 199(5):1158-1165. PubMed ID: 29203268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fluorescent endoscopy superior to white light endoscopy. Detecting cancers of the urinary bladder earlier].
    Zaak D
    MMW Fortschr Med; 2002 Mar; 144(13):24-6. PubMed ID: 12001582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study.
    Jichlinski P; Guillou L; Karlsen SJ; Malmström PU; Jocham D; Brennhovd B; Johansson E; Gärtner T; Lange N; van den Bergh H; Leisinger HJ
    J Urol; 2003 Jul; 170(1):226-9. PubMed ID: 12796694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence ureterorenoscopy for urinary upper tract urothelial carcinoma ∼Preliminary prospective single centre trial∼.
    Fukuhara H; Kurabayashi A; Furihata M; Setuda S; Takahashi K; Murakami K; Tanaka T; Inoue K
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101617. PubMed ID: 31857216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fluorescence cystoscopy using 5-aminolevulinic acid].
    Jirsa M; Babjuk M; Petrík R; Dvorácek J; Urban M; Köhler O
    Cas Lek Cesk; 2003 Mar; 142(3):172-3. PubMed ID: 12756847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of digitized endoscopic imaging of 5-ALA-induced PPIX fluorescence to detect and diagnose oral premalignant and malignant lesions in vivo.
    Zheng W; Olivo M; Soo KC
    Int J Cancer; 2004 Jun; 110(2):295-300. PubMed ID: 15069697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of hexaminolevulinate (Hexvix(®)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study.
    Lapini A; Minervini A; Masala A; Schips L; Pycha A; Cindolo L; Giannella R; Martini T; Vittori G; Zani D; Bellomo F; Cosciani Cunico S
    Surg Endosc; 2012 Dec; 26(12):3634-41. PubMed ID: 22729704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).
    Inoue K; Matsuyama H; Fujimoto K; Hirao Y; Watanabe H; Ozono S; Oyama M; Ueno M; Sugimura Y; Shiina H; Mimata H; Azuma H; Nagase Y; Matsubara A; Ito YM; Shuin T
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():91-96. PubMed ID: 26751700
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
    Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
    BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors.
    Filbeck T; Roessler W; Knuechel R; Straub M; Kiel HJ; Wieland WF
    Urology; 1999 Jan; 53(1):77-81. PubMed ID: 9886592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Photodynamic diagnosis of urothelial neoplasms after intravesicular instillation of 5-aminolevulinic acid].
    Kriegmair M; Baumgartner R; Knüchel R; Ehsan A; Steinbach P; Lumper W; Hofstädter F; Hofstetter A
    Urologe A; 1994 Jul; 33(4):270-5. PubMed ID: 7941171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Fluorescent diagnostics of urinary bladder cancer].
    Lopatkin NA; Kamalov AA; Kudriavtsev IuV; Tokarev FV
    Urologiia; 2000; (4):3-6. PubMed ID: 11186690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-magnification vascular imaging to reject false-positive sites in situ during Hexvix® fluorescence cystoscopy.
    Lovisa B; Jichlinski P; Weber BC; Aymon D; van den Bergh H; Wagnières G
    J Biomed Opt; 2010; 15(5):051606. PubMed ID: 21054080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.